Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene
- 18 September 2008
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 26 (50), 6405-6414
- https://doi.org/10.1016/j.vaccine.2008.08.069
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcriptionProceedings of the National Academy of Sciences, 2007
- Highly Attenuated Rabies Virus–Based Vaccine Vectors Expressing Simian‐Human Immunodeficiency Virus89.6PEnv and Simian Immunodeficiency Virusmac239Gag Are Safe in Rhesus Macaques and Protect from an AIDS‐Like DiseaseThe Journal of Infectious Diseases, 2007
- Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosisVaccine, 2005
- Characterization of P gene-deficient rabies virus: Propagation, pathogenicity and antigenicityVirus Research, 2005
- Oral vaccination of dogs with recombinant rabies virus vaccinesVirus Research, 2005
- Human antibody–Fc receptor interactions illuminated by crystal structuresNature Reviews Immunology, 2004
- Evaluation of lumpy skin disease virus, a capripoxvirus, as a replication-deficient vaccine vectorJournal of General Virology, 2003
- Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly ImmunogenicJournal of Virology, 2003
- IFN-γ-independent IgG2a production in mice infected with viruses and parasitesInternational Immunology, 2000
- Evidence for a viral superantigen in humansNature, 1992